3862 results for «303»
3862 results
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Abstracts in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!
Challenging cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!
TAVI and others
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.
Complication cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.
Session for the Co-medicals in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!
Cases in mitral
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging mitral cases, such as MitraClip therapy for dynamic mitral regurgitation with repetitive heart failure exacerbation, transseptal mitral valve-in-valve implantation to elucidate a degree of concomitant aortic valve stenosis, and more!
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
The resurgence of renal denervation
25 Jun 2020 – From PCR e-Course
Following the latest trial results showing the safety and efficacy of renal denervation to treat hypertension, this session will provide you with a high-level update on where we stand currently and where we are moving in the near future.
This session was originally presented during PCR e-Course...
Vulnerable plaques and vulnerable patients
27 Jun 2020 – From PCR e-Course 2020
Watch this session to learn more about latest advances in detecting and treating vulnerable plaques and patients, in predicting clinical events, and the imaging options for prevention and treatment.
This session was originally presented during PCR e-Course 2020.
PCR e-Course 2020 Clinical cases
25 Jun 2020 – From PCR e-Course 2020
Watch a series of best clinical cases presented at the PCR e-Course 2020:
- ACS-patient with culprit in a coronary ectasia
- Coronary stenting in an ectatic artery
- Challenging PCI after aortic valve-in-valve implantation
- Cisplatin-induced coronary artery thrombosis presented as ACS
- MOCA I study: microvascular obstruction measured using dMVR
- The many faces of in-stent...
The burden of non-COVID patients: caring for the left-behind
26 Jun 2020 – From PCR e-Course 2020
Despite the dramatic consequences of the pandemic, there is still a need for treating chronic cardiovascular diseases. In this session, you will find out more about the strategies that can be used to deal with the people left behind.
This session was originally presented during PCR e-Course...
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
Basics of peripheral interventions
25 Jun 2020 – From PCR e-Course 2020
Learn more about how to deal with a complex cross over, how to treat a long superficial femoral artery occlusion and how to decide which material to use after POBA in long SFA occlusive disease.
This session was originally presented during PCR e-Course 2020.
TAVI: Full one-year Evolut low-risk randomised results and economic implications
EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications to understand the potential drivers for TAVI cost-effectives in Europe.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
CABG or PCI in patients with left main coronary artery disease
27 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to be updated on clinical outcomes in patients with left main lesion treated by PCI or CABG and to understand the different criteria who play a major role in decision making between PCI and CABG.
This session was originally presented during...
TAVI for bicuspid valves with Evolut: BIVOLUT-X registry
Learn more about transcatheter treatment of bicuspid aortic valves with the EVOLUT platform, the BIVOLUT-X registry design, and key outcomes and practical implications of the study.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
How to select the most appropriate DAPT strategy in each patient?
Watch this case discussion if you want to tailor DAPT strategies based on balance between ischaemic and bleeding risks in specific clinical situations and to review the different options regarding drug choices, doses, and duration of treatment.
This session was originally presented during PCR e-Course 2020.
